Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Chlamydia
1.2.3 Syphilis
1.2.4 Gonorrhea
1.2.5 Herpes Simplex Virus
1.2.6 Human Papilloma Virus
1.2.7 Human Immunodeficiency Virus
1.2.8 Others
1.3 Market by Application
1.3.1 Global Sexually Transmitted Diseases (STD) Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Laboratory Testing
1.3.3 Point of Care (POC) Testing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Diseases (STD) Testing Market Perspective (2018-2033)
2.2 Sexually Transmitted Diseases (STD) Testing Growth Trends by Region
2.2.1 Global Sexually Transmitted Diseases (STD) Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Sexually Transmitted Diseases (STD) Testing Historic Market Size by Region (2018-2023)
2.2.3 Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Region (2024-2033)
2.3 Sexually Transmitted Diseases (STD) Testing Market Dynamics
2.3.1 Sexually Transmitted Diseases (STD) Testing Industry Trends
2.3.2 Sexually Transmitted Diseases (STD) Testing Market Drivers
2.3.3 Sexually Transmitted Diseases (STD) Testing Market Challenges
2.3.4 Sexually Transmitted Diseases (STD) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Revenue
3.1.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Revenue (2018-2023)
3.1.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Players (2018-2023)
3.2 Global Sexually Transmitted Diseases (STD) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sexually Transmitted Diseases (STD) Testing Revenue
3.4 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio
3.4.1 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Testing Revenue in 2022
3.5 Sexually Transmitted Diseases (STD) Testing Key Players Head office and Area Served
3.6 Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
3.7 Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Type
4.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Type (2018-2023)
4.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2024-2033)
5 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Application
5.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Application (2018-2023)
5.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
6.2 North America Sexually Transmitted Diseases (STD) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023)
6.4 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
7.2 Europe Sexually Transmitted Diseases (STD) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023)
7.4 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
8.2 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
9.2 Latin America Sexually Transmitted Diseases (STD) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023)
9.4 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
10.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ROCHE HOLDINGS
11.1.1 ROCHE HOLDINGS Company Detail
11.1.2 ROCHE HOLDINGS Business Overview
11.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Introduction
11.1.4 ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.1.5 ROCHE HOLDINGS Recent Development
11.2 BIOMERIEUX
11.2.1 BIOMERIEUX Company Detail
11.2.2 BIOMERIEUX Business Overview
11.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Introduction
11.2.4 BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.2.5 BIOMERIEUX Recent Development
11.3 HOLOGIC
11.3.1 HOLOGIC Company Detail
11.3.2 HOLOGIC Business Overview
11.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Introduction
11.3.4 HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.3.5 HOLOGIC Recent Development
11.4 BECTON DICKINSON
11.4.1 BECTON DICKINSON Company Detail
11.4.2 BECTON DICKINSON Business Overview
11.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Introduction
11.4.4 BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.4.5 BECTON DICKINSON Recent Development
11.5 ORASURE
11.5.1 ORASURE Company Detail
11.5.2 ORASURE Business Overview
11.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Introduction
11.5.4 ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.5.5 ORASURE Recent Development
11.6 DANAHER
11.6.1 DANAHER Company Detail
11.6.2 DANAHER Business Overview
11.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Introduction
11.6.4 DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.6.5 DANAHER Recent Development
11.7 AFFYMETRIX
11.7.1 AFFYMETRIX Company Detail
11.7.2 AFFYMETRIX Business Overview
11.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Introduction
11.7.4 AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.7.5 AFFYMETRIX Recent Development
11.8 ABBOTT LABORATORIES
11.8.1 ABBOTT LABORATORIES Company Detail
11.8.2 ABBOTT LABORATORIES Business Overview
11.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
11.8.4 ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.8.5 ABBOTT LABORATORIES Recent Development
11.9 BIO-RAD LABORATORIES
11.9.1 BIO-RAD LABORATORIES Company Detail
11.9.2 BIO-RAD LABORATORIES Business Overview
11.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
11.9.4 BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.9.5 BIO-RAD LABORATORIES Recent Development
11.10 DIASORIN
11.10.1 DIASORIN Company Detail
11.10.2 DIASORIN Business Overview
11.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Introduction
11.10.4 DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.10.5 DIASORIN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Chlamydia
Table 3. Key Players of Syphilis
Table 4. Key Players of Gonorrhea
Table 5. Key Players of Herpes Simplex Virus
Table 6. Key Players of Human Papilloma Virus
Table 7. Key Players of Human Immunodeficiency Virus
Table 8. Key Players of Others
Table 9. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Sexually Transmitted Diseases (STD) Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Sexually Transmitted Diseases (STD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region (2018-2023)
Table 13. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region (2024-2033)
Table 15. Sexually Transmitted Diseases (STD) Testing Market Trends
Table 16. Sexually Transmitted Diseases (STD) Testing Market Drivers
Table 17. Sexually Transmitted Diseases (STD) Testing Market Challenges
Table 18. Sexually Transmitted Diseases (STD) Testing Market Restraints
Table 19. Global Sexually Transmitted Diseases (STD) Testing Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Sexually Transmitted Diseases (STD) Testing Market Share by Players (2018-2023)
Table 21. Global Top Sexually Transmitted Diseases (STD) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2022)
Table 22. Ranking of Global Top Sexually Transmitted Diseases (STD) Testing Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
Table 26. Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2018-2023)
Table 30. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2024-2033)
Table 32. Global Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2018-2023)
Table 34. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2024-2033)
Table 36. North America Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 42. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 43. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2024-2033) & (US$ Million)
Table 45. Latin America Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 48. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 51. ROCHE HOLDINGS Company Detail
Table 52. ROCHE HOLDINGS Business Overview
Table 53. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Product
Table 54. ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 55. ROCHE HOLDINGS Recent Development
Table 56. BIOMERIEUX Company Detail
Table 57. BIOMERIEUX Business Overview
Table 58. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Product
Table 59. BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 60. BIOMERIEUX Recent Development
Table 61. HOLOGIC Company Detail
Table 62. HOLOGIC Business Overview
Table 63. HOLOGIC Sexually Transmitted Diseases (STD) Testing Product
Table 64. HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 65. HOLOGIC Recent Development
Table 66. BECTON DICKINSON Company Detail
Table 67. BECTON DICKINSON Business Overview
Table 68. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Product
Table 69. BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 70. BECTON DICKINSON Recent Development
Table 71. ORASURE Company Detail
Table 72. ORASURE Business Overview
Table 73. ORASURE Sexually Transmitted Diseases (STD) Testing Product
Table 74. ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 75. ORASURE Recent Development
Table 76. DANAHER Company Detail
Table 77. DANAHER Business Overview
Table 78. DANAHER Sexually Transmitted Diseases (STD) Testing Product
Table 79. DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 80. DANAHER Recent Development
Table 81. AFFYMETRIX Company Detail
Table 82. AFFYMETRIX Business Overview
Table 83. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Product
Table 84. AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 85. AFFYMETRIX Recent Development
Table 86. ABBOTT LABORATORIES Company Detail
Table 87. ABBOTT LABORATORIES Business Overview
Table 88. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Product
Table 89. ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 90. ABBOTT LABORATORIES Recent Development
Table 91. BIO-RAD LABORATORIES Company Detail
Table 92. BIO-RAD LABORATORIES Business Overview
Table 93. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Product
Table 94. BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 95. BIO-RAD LABORATORIES Recent Development
Table 96. DIASORIN Company Detail
Table 97. DIASORIN Business Overview
Table 98. DIASORIN Sexually Transmitted Diseases (STD) Testing Product
Table 99. DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 100. DIASORIN Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sexually Transmitted Diseases (STD) Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Sexually Transmitted Diseases (STD) Testing Market Share by Type: 2022 VS 2033
Figure 3. Chlamydia Features
Figure 4. Syphilis Features
Figure 5. Gonorrhea Features
Figure 6. Herpes Simplex Virus Features
Figure 7. Human Papilloma Virus Features
Figure 8. Human Immunodeficiency Virus Features
Figure 9. Others Features
Figure 10. Global Sexually Transmitted Diseases (STD) Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 11. Global Sexually Transmitted Diseases (STD) Testing Market Share by Application: 2022 VS 2033
Figure 12. Laboratory Testing Case Studies
Figure 13. Point of Care (POC) Testing Case Studies
Figure 14. Sexually Transmitted Diseases (STD) Testing Report Years Considered
Figure 15. Global Sexually Transmitted Diseases (STD) Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Sexually Transmitted Diseases (STD) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region: 2022 VS 2033
Figure 18. Global Sexually Transmitted Diseases (STD) Testing Market Share by Players in 2022
Figure 19. Global Top Sexually Transmitted Diseases (STD) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue in 2022
Figure 21. North America Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Sexually Transmitted Diseases (STD) Testing Market Share by Country (2018-2033)
Figure 23. United States Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Country (2018-2033)
Figure 27. Germany Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Share by Region (2018-2033)
Figure 35. China Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Country (2018-2033)
Figure 43. Mexico Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Share by Country (2018-2033)
Figure 47. Turkey Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. ROCHE HOLDINGS Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 50. BIOMERIEUX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 51. HOLOGIC Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 52. BECTON DICKINSON Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 53. ORASURE Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 54. DANAHER Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 55. AFFYMETRIX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 56. ABBOTT LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 57. BIO-RAD LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 58. DIASORIN Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed